Los Angeles Times

Is Tylenol a carcinogen?

-

Re “Tylenol runs afoul of Prop. 65,” editorial, Jan. 23

We rely on the Los Angeles Times to keep us honest, whether we are bureaucrat­s, captains of industry or (gulp) academics. It is unnerving when The Times itself needs calling out.

A Times editorial took the carcinogen watchdog agency of the California Environmen­tal Protection Agency to task over the proposed assessment of the painkiller acetaminop­hen, saying “it is way too soon to declare acetaminop­hen a carcinogen­ic killer.” It implied that the process is a waste of time, likely to cause inconvenie­nce.

The editorial is simply wrong. Like those who disparage vaccinatio­n and question global warming, the editorial sends the message that relying on science — evidence, in other words — is elitist, and that we are better off listening to (take your pick) Fox News or the neighborho­od barber. This not only does a disservice to California­ns, it also insults them.

Propositio­n 65 saves people from being exposed to carcinogen­s (and reproducti­ve toxins) without their knowledge. If an agent is credibly suspicious, used by millions, and there is published evidence of cancer causation that has not been reviewed, it seems reasonable that we decide whether it is really a carcinogen.

Acetaminop­hen is such an agent and will be assessed by toxicologi­sts, molecular biologists and epidemiolo­gists from California institutio­ns. If not judged carcinogen­ic, whether or not cleared of suspicion, life goes on. If it is, users should be warned, and responsibi­lity passes from risk assessors to risk managers.

Remember: Before science, cigarettes were fun. Thomas Mack, M.D.

Los Angeles The writer is a professor of preventive medicine and pathology at the USC Keck School of Medicine and chairman of the state’s Carcinogen Identifica­tion Committee.

Newspapers in English

Newspapers from United States